Albert, an Oakland, California company also known as Albert Invent, has raised a $55m Series B led by TCV, it announced on October 13, 2026.
New investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital and Legion VC joined the round, alongside existing backers Coatue, J.P. Morgan Growth Equity Partners, Index Ventures and Applied Ventures.
The company did not disclose a valuation. AI Weekly, citing Forbes, reported that the round valued Albert at about $340m, a figure attributed to one unnamed source.
“Enterprise AI for chemistry has to be built from the ontology up; the language, data, workflows, and decisions for R&D are deeply specialized.”Nick Talken, CEO and co-founder, Albert
What Albert does
Albert sells software for chemistry and materials research. Its operating system records experiments and structures lab data, and its assistant, Ask Albert, lets scientists ask questions in natural language. The assistant searches past work so teams do not repeat experiments, suggests formulation candidates, designs experiments and runs data analysis.
Alongside the funding, the company announced results for Valence, its chemistry-specific model. Albert said its own research shows Valence is 45 times more accurate than general-purpose AI at retrieving correct answers to scientific queries, measured on FormBench, a formulation chemistry benchmark the company built itself. Earlier, Albert said it had trained a foundation model on around 15 million molecules.
Albert names AkzoNobel, Avient, BASF, Chemours, Clorox, Henkel, Kenvue and Nouryon as partners. It said project creation on its platform grew 26 times year over year, the number of scientists using it rose six times across 44 countries, and workflow creation grew four times. It did not disclose revenue or headcount.
Who invested
TCV, which led the round, had already backed Albert in earlier financings. TCV partner Morgan Gerlack said chemistry R&D still runs largely on spreadsheets and institutional memory, and called Albert an example of where vertical AI is going.
Chief executive and co-founder Nick Talken said the company's team comes from the chemical industry, and that the funding supports its aim of letting each customer build a model of its own science grounded in its experimental data. According to AI Weekly, Talken previously led digital R&D at Henkel.
What the money is for
Albert said the money will be used to expand its chemistry-native AI so that customers can shorten development cycles and bring products to market faster. The company also stresses enterprise controls such as zero data retention, fine-grained access rights and audit trails of the AI's reasoning.
The funding so far
Albert raised a $22.5m Series A from Coatue in 2024, with Homebrew among the participants, according to Homebrew. In February 2025 it added $20m in a round led by J.P. Morgan Growth Equity Partners, with Coatue and TCV taking part, which Pulse 2.0 said brought total funding to more than $45m. Homebrew said that extension valued the company at $270m, twice the price of the previous close.
The Series B therefore takes Albert's disclosed funding to more than $100m.
Company website: albertinvent.com